J. Gaillat

1.3k total citations
49 papers, 837 citations indexed

About

J. Gaillat is a scholar working on Epidemiology, Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Gaillat has authored 49 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 14 papers in Health and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Gaillat's work include Influenza Virus Research Studies (18 papers), Vaccine Coverage and Hesitancy (14 papers) and Pneumonia and Respiratory Infections (11 papers). J. Gaillat is often cited by papers focused on Influenza Virus Research Studies (18 papers), Vaccine Coverage and Hesitancy (14 papers) and Pneumonia and Respiratory Infections (11 papers). J. Gaillat collaborates with scholars based in France, Switzerland and United States. J. Gaillat's co-authors include G. Gavazzi, Jean‐Pierre Michel, Odile Launay, Didier Bouhassira, Marc Paccalin, Robert W. Johnson, Marc Labétoulle, L. Salleras Sanmartí, J. Gorjão Clara and Marc Bijl and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Pain.

In The Last Decade

J. Gaillat

46 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Gaillat France 15 568 170 166 139 110 49 837
George Kassianos United Kingdom 16 532 0.9× 117 0.7× 188 1.1× 71 0.5× 108 1.0× 42 747
Daniel R. Hinthorn United States 17 434 0.8× 194 1.1× 79 0.5× 122 0.9× 30 0.3× 46 989
Cristiano Alicino Italy 21 749 1.3× 262 1.5× 188 1.1× 67 0.5× 40 0.4× 46 1.1k
Ernest Kuchar Poland 17 412 0.7× 256 1.5× 152 0.9× 27 0.2× 16 0.1× 134 921
Rick A. Barbarash United States 11 1.2k 2.1× 281 1.7× 15 0.1× 106 0.8× 146 1.3× 15 1.5k
Paige Lewis United States 21 674 1.2× 332 2.0× 406 2.4× 55 0.4× 15 0.1× 48 1.2k
Jan Smetana Czechia 10 446 0.8× 144 0.8× 119 0.7× 21 0.2× 20 0.2× 25 697
Masahiro Ishikane Japan 16 420 0.7× 386 2.3× 40 0.2× 61 0.4× 18 0.2× 120 1.1k
Mei Chong Canada 23 882 1.6× 226 1.3× 54 0.3× 63 0.5× 15 0.1× 58 1.4k
İ̇lker İnanç Balkan Türkiye 19 265 0.5× 445 2.6× 84 0.5× 110 0.8× 19 0.2× 81 1.1k

Countries citing papers authored by J. Gaillat

Since Specialization
Citations

This map shows the geographic impact of J. Gaillat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Gaillat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Gaillat more than expected).

Fields of papers citing papers by J. Gaillat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Gaillat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Gaillat. The network helps show where J. Gaillat may publish in the future.

Co-authorship network of co-authors of J. Gaillat

This figure shows the co-authorship network connecting the top 25 collaborators of J. Gaillat. A scholar is included among the top collaborators of J. Gaillat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Gaillat. J. Gaillat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lemaître, Magali, Fabrice Carrat, Pascal Crépey, et al.. (2022). Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018. Influenza and Other Respiratory Viruses. 16(4). 717–725. 25 indexed citations
3.
Gaillat, J.. (2019). Défiance vis-à-vis de la vaccination : comment lever les freins ?. Revue des Maladies Respiratoires. 36(8). 962–970. 4 indexed citations
4.
Ecarnot, Fiona, Gaetano Crepaldi, Philippe Juvin, et al.. (2019). Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting. BMC Public Health. 19(1). 1698–1698. 51 indexed citations
5.
Beaufils, É., M.-A. Dommergues, J. Gaillat, et al.. (2016). Coqueluche : où en est-on en France 10ans après la mise en place de la stratégie vaccinale du cocooning ?. Gynécologie Obstétrique & Fertilité. 44(10). 591–597. 3 indexed citations
7.
Roubaud‐Baudron, Claire, E. Forestier, T. Fraisse, et al.. (2016). Tolerance of subcutaneously administered antibiotics: a French national prospective study. Age and Ageing. 46(1). 151–155. 29 indexed citations
8.
Johnson, Robert W., Marc Bijl, Elisabetta Franco, et al.. (2015). Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. PubMed. 3(4). 109–120. 176 indexed citations
9.
Forestier, E., Marc Paccalin, Claire Roubaud‐Baudron, et al.. (2014). Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks. Clinical Microbiology and Infection. 21(4). 370.e1–370.e3. 38 indexed citations
10.
Duracinský, Martin, Marc Paccalin, G. Gavazzi, et al.. (2014). ARIZONA study: is the risk of post-herpetic neuralgia and its burden increased in the most elderly patients?. BMC Infectious Diseases. 14(1). 529–529. 9 indexed citations
11.
Fraisse, T., Marc Paccalin, Virginie Vitrat, et al.. (2014). Aminoglycosides use in patients over 75 years old. Age and Ageing. 43(5). 676–681. 18 indexed citations
12.
Gavazzi, G., Emmanuelle Cambau, Patrice François, et al.. (2013). Diagnostic criteria for urinary tract infection in hospitalized elderly patients over 75 years of age: A multicenter cross-sectional study. Médecine et Maladies Infectieuses. 43(5). 189–194. 21 indexed citations
13.
Rabaud, Christian, O. Rogeaux, Odile Launay, et al.. (2013). Early antiviral treatment fails to completely prevent herpes-related pain. Médecine et Maladies Infectieuses. 43(11-12). 461–466. 9 indexed citations
14.
Bouhour, Damien, G. Gavazzi, J. Gaillat, et al.. (2012). Survey of vaccination policies in French healthcare institutions. Médecine et Maladies Infectieuses. 42(4). 161–166. 9 indexed citations
15.
Gaillat, J.. (2010). Impact des programmes de vaccination généralisée. De l'enfant en France au XXe siècle?. La Revue du praticien. 60(8). 2 indexed citations
16.
Jund, J., et al.. (2008). La vaccination anticoquelucheuse de l’adulte et des professionnels de santé est-elle connue et appliquée ?. Médecine et Maladies Infectieuses. 38(7). 372–377. 10 indexed citations
17.
Carrat, Fabrice, et al.. (2007). General practitioners’ management of influenza with or without neuraminidase inhibitors. European Journal of General Practice. 13(3). 157–159. 1 indexed citations
18.
Laurichesse, H., Albert Sotto, É. Bonnet, et al.. (2001). Pre- and In-Hospital Management of Community-Acquired Pneumonia in Southern France, 1998–99. European Journal of Clinical Microbiology & Infectious Diseases. 20(11). 770–778. 7 indexed citations
19.
Gaillat, J.. (2001). Que penser du traitement antiviral de la grippeen l’an 2001 ?. La Revue de Médecine Interne. 22(1). 53–61. 1 indexed citations
20.
Gaillat, J.. (1993). A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis. Journal of Antimicrobial Chemotherapy. 31(suppl C). 139–151. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026